Explore how product hopping and REMS abuse block generic drug competition. Learn about key antitrust cases like NY v. Actavis, FTC enforcement actions, and the economic impact on healthcare costs.
Learn more...Generic substitution was meant to cut drug costs, but pharmacy reimbursement systems now reward higher-priced generics. Learn how PBM pricing, MAC lists, and spread pricing undermine savings-and who really benefits.
Learn more...When switching patients to generic NTI drugs, clear communication and careful monitoring are essential. Learn what to say, when to test, and how to build trust-backed by FDA guidelines and real patient data.
Learn more...